Status:

TERMINATED

Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC

Lead Sponsor:

Hellenic Oncology Research Group

Collaborating Sponsors:

University Hospital of Crete

Conditions:

Non-small-cell Lung Cancer

Eligibility:

All Genders

70-85 years

Phase:

PHASE3

Brief Summary

This trial will compare the efficacy of the docetaxel and gemcitabine combination versus monotherapy with gemcitabine as first-line treatment in elderly patients with advanced NSCLC

Detailed Description

Docetaxel and gemcitabine are well known active agents in the treatment of NSCLC. The standard treatment of elderly patients with advanced NSCLC is monotherapy with a third generation agent. However, ...

Eligibility Criteria

Inclusion

  • Histologically- or cytologically- confirmed Non-Small-Cell Lung Cancer
  • Stage IIIB/IV
  • No prior chemotherapy
  • Presence of two-dimensional measurable disease. The measurable disease should not have been irradiated.
  • Absence or irradiated and stable central nervous system metastatic disease
  • Life expectancy of more than 3 months
  • Age ≥ 70 years.
  • Performance status (WHO) \< 3
  • Patients "non-frail" according to comprehensive geriatric assessment
  • Adequate bone marrow function (Absolute neutrophil count \> 1000/mm\^3, Platelet count \> 100000/mm\^3, Hemoglobin \> 9gr/mm\^3).
  • Adequate liver (Bilirubin \< 1.5 times upper limit of normal and SGOT/SGPT \< 2 times upper limit of normal) and renal function (creatinine \< 2mg/dl).
  • Adequate cardiac function (LVEF \> 50%).
  • Informed consent.

Exclusion

  • Psychiatric illness or social situation that would preclude study compliance.
  • Other concurrent uncontrolled illness.
  • Other invasive malignancy within the past 5 years except nonmelanoma skin cancer.
  • No presence of a reliable care giver
  • Other concurrent investigational agents.

Key Trial Info

Start Date :

December 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2010

Estimated Enrollment :

106 Patients enrolled

Trial Details

Trial ID

NCT00442026

Start Date

December 1 2006

End Date

May 1 2010

Last Update

June 27 2012

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

University General Hospital of Alexandroupolis, Dep of Medical Oncology

Alexandroupoli, Greece

2

"Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine

Athens, Greece

3

401 Military Hospital, Medical Oncology Unit

Athens, Greece

4

Air Forces Military Hospital, Dep of Medical Oncology

Athens, Greece